LORATADINE-D 12 HOUR TABLET

loratadine, Pseudoephedrine sulfate
$0.7989per EA
OTC

Strength

5; 120 mg/1; mg/1

NDC

45802012246

Classification

Generic

Dosage Form

TABLET, FILM COATED, EXTENDED RELEASE

Route

ORAL

Last Updated

4/22/2026

Approval Type

Generic (ANDA)

FDA Application

ANDA076050

On Market Since

4/10/2018

Pharmacological Classes

Adrenergic alpha-Agonists
alpha-Adrenergic Agonist

Price History

1W

0.0%

1M

+0.5%

3M

+0.5%

6M

+1.4%

1Y

-0.9%

3Y

-0.4%

5Y

-1.8%

All

+1.2%